Drug-Eluting Stent Payment Based On UK Prices Sets Precedent – MedPAC
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Payment Advisory Commission expressed concern over the potential precedent set by the Centers for Medicare & Medicaid Services' recent decision to base the payment rate for drug-eluting stents on overseas prices